Top compounds associated with response to MSANTD2


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.002 1
mRNA Sunitinib CTRPv2 pan-cancer AAC -0.0019 1
mRNA SB-225002 CTRPv2 pan-cancer AAC 0.0016 1
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.0017 1
mRNA TW 37 GDSC1000 pan-cancer AAC 0.0017 1
mRNA SR-II-138A CTRPv2 pan-cancer AAC -0.0016 1
mRNA Vinblastine GDSC1000 pan-cancer AAC -0.0017 1
mRNA erismodegib CTRPv2 pan-cancer AAC 0.0019 1
mRNA BMS-195614 CTRPv2 pan-cancer AAC -0.0018 1
mRNA Vorinostat GDSC1000 pan-cancer AAC 0.0014 1
Download CSV